A Smart, "Always -On" Health Monitoring System

NCT ID: NCT02865070

Last Updated: 2022-06-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

38 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-03-31

Study Completion Date

2021-11-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a pilot study is to test a wireless, skin-sensor device against current technology in the NICU to monitor vitals

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a single center, prospective, observational study that will recruit subjects from Lurie Children's Hospital and Prentice Women's Hospital to test a new wireless vitals monitor against the current vitals monitors used in the NICU. Patients will be neonates in different age brackets.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Premature Birth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2 infants (ages 1-6mo) non-NICU setting

Skin Sensor

Intervention Type DEVICE

Wireless vitals monitor

10 babies (full term, ages 37-42 weeks)

Skin Sensor

Intervention Type DEVICE

Wireless vitals monitor

5 babies (premature, ages 34-37 weeks)

Skin Sensor

Intervention Type DEVICE

Wireless vitals monitor

5 babies (premature, ages 31-34 weeks)

Skin Sensor

Intervention Type DEVICE

Wireless vitals monitor

5 babies (premature, ages 28-31 weeks)

Skin Sensor

Intervention Type DEVICE

Wireless vitals monitor

5 babies (premature, ages 25-28 weeks)

Skin Sensor

Intervention Type DEVICE

Wireless vitals monitor

5 babies (premature, ages 23-25 weeks)

Skin Sensor

Intervention Type DEVICE

Wireless vitals monitor

30 babies (any gestational age under 6 months)

Skin Sensor

Intervention Type DEVICE

Wireless vitals monitor

25 neonates (ages 24-29 weeks for sub-study)

Skin Sensor

Intervention Type DEVICE

Wireless vitals monitor

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Skin Sensor

Wireless vitals monitor

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Neonates in different age cohorts from ages 25 weeks gestational age to fullterm infants or infants up to 6 months of age, selected with assistance of NICU staff
* Currently in NICU and requiring monitoring for heart rate, ECG, respiratory rate, temperature, and pulse oximetry
* Parents able to understand and provide informed consent for study
* Infants enrolled in the Pre-Vent study (sub-study only)

Exclusion Criteria

* Over 6 months of age
* Hemodynamic or other instability precluding testing of new monitoring with concurrent standards
* Infants at imminent risk of death and neonates with a skin abnormality that precludes assessment
Maximum Eligible Age

6 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northwestern University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amy Paller

Professor in Dermatology and Pediatrics

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amy Paller, MD

Role: PRINCIPAL_INVESTIGATOR

Northwestern University, Lurie Children's Hospital Department of Dermatology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lurie Children's Hospital

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MA06072012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Non-invasive Ventilation
NCT07186790 NOT_YET_RECRUITING
Non-invasive Ventilation in Preterm Infants
NCT05987800 ACTIVE_NOT_RECRUITING NA